Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.89 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.89 |
| ▸ | KCNA1 | Q09470 | 1/20 | 0.89 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.80 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.80 |
| ▸ | ATM | Q13315 | 1/20 | 0.80 |
| ▸ | DNM1 | Q05193 | 4/20 | 0.39 |
| ▸ | SLC22A1 | O15245 | 3/20 | 0.36 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tetrylammonium SCHEMBL11335650 | 0.95 | TSHR (0.80) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL11335886 | 0.95 | TSHR (0.80) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL22364476 | 0.95 | TSHR (0.80) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL27614204 | 0.95 | TSHR (0.80) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL5484929 | 0.94 | TSHR (1.00) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL16267 | 0.94 | — | — | |
| Tetrylammonium SCHEMBL4078612 | 0.94 | TSHR (1.00) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL6366220 | 0.91 | TSHR (0.73) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL23528606 | 0.89 | TSHR (0.89) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL11162171 | 0.89 | TSHR (0.89) | TSHRNFKB1KCNA1KDM4EPMP22 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 391 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122091514-A | Negative electrode material for packaging tin phosphide by using few-layer MXene curling and preparation method thereof | — | 2026-05-26 | — | — | CN | claimed |
| CN-117894498-A | High-conductivity electrode slurry, preparation method and application | 武汉万度光能研究院有限责任公司 | 2024-04-16 | — | — | CN | claimed |
| US-20240082753-A1 | POLYMERIZATION INHIBITING AND EMULSION BREAKING COMPOSITION AND METHOD OF USE THEREOF | DORF KETAL CHEMICALS (INDIA) PRIVATE LIMITED (IN) | 2024-03-14 | — | — | US | claimed |
| CN-117637357-A | Pretreatment method of core package for super capacitor | 东莞东阳光科研发有限公司 | 2024-03-01 | — | — | CN | claimed |
| EP-4281520-A1 | POLYMERIZATION INHIBITING AND EMULSION BREAKING COMPOSITION AND METHOD OF USE THEREOF | Dorf Ketal Chemicals (India) Private Limited (IN) | 2023-11-29 | — | — | EP | claimed |
| CN-114965823-A | Space resolution proteomics method based on laser capture microdissection technology | 上海交通大学 | 2022-08-30 | — | — | CN | claimed |
| WO-2022157586-A1 | POLYMERIZATION INHIBITING AND EMULSION BREAKING COMPOSITION AND METHOD OF USE THEREOF | DORF KETAL CHEMICALS (INDIA) PRIVATE LIMITED (IN) | 2022-07-28 | — | — | WO | claimed |
| EP-3394057-B1 | SYNTHETIC METHOD FOR PREPARATION OF (S)-(2R,3R,11BR)-3-ISOBUTYL-9,10-DIMETHOXY-2,3,4,6,7,11B-HEXAHYDRO-1H-PYRIDO[2,1,-A]LSOQUINOLIN-2-YL 2-AMINO-3-METHYLBUTANOATE DI(4-METHYLBENZENESULFONATE) | NEUROCRINE BIOSCIENCES INC (US) | 2022-03-30 | — | — | EP | claimed |
| CN-113881210-A | High-fluidity transparent polycarbonate material and preparation method thereof | 万华化学集团股份有限公司 | 2022-01-04 | — | — | CN | claimed |
| US-11071750-B2 | Soluble adducts of boric acid or derivatives and precursors thereof with chitosan oligosaccharide derivatives | BIOPOLIFE SRL (IT) | 2021-07-27 | — | — | US | claimed |
| US-20050147553-A1 | Sidewall-functionalized carbon nanotubes, and methods for making the same | NEW YORK, RESEARCH FOUNDATION OF STATE UNIVERSITY OF, THE | 2005-07-07 | — | — | US | claimed |
| US-20050020669-A1 | Process for the preparation of the 14beta-hydroxy-baccatin III-1, 14-carbonate | INDENA S.P.A. (IT) | 2005-01-27 | — | — | US | claimed |
| US-6773822-B2 | ANTIFUNGAL AGENT MAY BE PRESENT IN THE GYPSUM CORE AND/OR ON ONE OR BOTH OF THE PAPER FACINGS, AND MAY BE ENCAPSULATED IN A MATERIAL THAT RELEASES THE ANTIFUNGAL AGENT OVER TIME AND/OR UPON EXPOSURE TO MOISTURE. | TEMPLE-INLAND FOREST PRODUCTS CORPORATION | 2004-08-10 | — | — | US | claimed |
| EP-1436278-A1 | A PROCESS FOR THE PREPARATION OF THE 14BETA-HYDROXY-BACCATIN III-1,14-CARBONATE | INDENA S.p.A. (IT) | 2004-07-14 | — | — | EP | claimed |
| WO-2003035634-A1 | A PROCESS FOR THE PREPARATION OF THE 14BETA-HYDROXY-BACCATIN III-1,14-CARBONATE | INDENA S.P.A. (IT) | 2003-05-01 | — | — | WO | claimed |
| US-6245879-B1 | REACTING, UNDER CONDENSATION POLYMERIZATION CONDITIONS, TEREPHTHALIC ACID AND EXCESS 1,3-PROPANEDIOL, VACUUM DISTILLING AND CONDENSING UNREACTED DIOL; ADDING BASE TO RAISE PH OF CONDENSATE, DISTILLING AND RECYCLING DIOL | SHELL OIL COMPANY | 2001-06-12 | — | — | US | claimed |
| US-5608182-A | TETRAALKYLAMMONIUM BOROHYDRIDE | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) | 1997-03-04 | — | — | US | claimed |
| US-5582808-A | PREVENTING ALDOL CONDENSATION OF REACTIVE CARBONYLS | BAKER HUGHES INCORPORATED (US) | 1996-12-10 | — | — | US | claimed |
| US-4534898-A | 1-Oxa-1-dethia-cephalosporin derivatives | MERCK & CO., INC. (US) | 1985-08-13 | — | — | US | claimed |
| US-4391993-A | TRIETHYLAMINE BORANE SOLVENT | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) | 1983-07-05 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050020669-A1 | Process for the preparation of the 14beta-hydroxy-baccatin III-1, 14-carbonate | CYP51A1, CYP8B1, EBP | TSHR 4875/4885NFKB1 157/4885KCNA1 4502/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.